Brooke N. McLain is a law clerk in Sterne Kessler’s Trial & Appellate Practice Group. She concentrates her practice in the area of patent litigation, including matters before federal district courts and the United States International Trade Commission. Brooke has experience handling matters in areas such as ANDA pharmaceutical litigation and the automotive industry.

While attending J. Reuben Clark Law School, Brooke served for two years as an articles editor for the BYU Law Review. She was a Judicial Extern for the Honorable Judge David Nuffer of the United States District Court for the District of Utah. Brooke also participated in the Giles Sutherland Rich Memorial Moot Court competition, the Trial Advocacy Team, the Health Law Society, and the Center for Conflict Resolution.

Prior to law school, Brooke received her B.A. in Molecular and Cellular Biology from Harvard, focusing her studies on genetics. Her wet lab research focused on C. elegans, drug interactions, and fluorescent microscopy.

  • J.D., J. Reuben Clark Law School
  • B.A., Molecular and Cellular Biology, Harvard University

  • U.S. District Court for the District of Colorado
  • Virginia

Related News & Insights

From Brooke N. McLain

In the News

February 28, 2024

Jury Awards Wirtgen $12.9M Against Caterpillar in Milling Machine Lawsuit

Equipment World

Firm Announcements

February 27, 2024

Sterne Kessler and Patterson IP Law Team Up to Secure $12.9M Wirtgen Win Over Caterpillar

Sterne, Kessler, Goldstein & Fox

In the News

February 27, 2024

Caterpillar Owes Deere $13 Million in Road-Milling Patent Trial

Bloomberg Law

In the News

February 26, 2024

Caterpillar to Pay Wirtgen $12.9M in Damages After Patent Battle

Construction Briefing

Bylined Articles

February 14, 2024

Rule and Procedural Developments at the ITC in 2023

Sterne, Kessler, Goldstein & Fox Daniel E. Yonan, Brooke N. McLain

Reports

February 14, 2024

2023 ITC Section 337 Year in Review: Analysis & Trends

Sterne, Kessler, Goldstein & Fox Multiple Authors

Press Release

February 14, 2024

Sterne Kessler Publishes 2023 ITC Section 337 Year in Review: Analysis & Trends Report

Sterne, Kessler, Goldstein & Fox

In the News

January 3, 2024

Teva Defeats Infringement Claims on Endocrine Drug

New Jersey Law Journal

Firm Announcements

January 3, 2024

Sterne Kessler Secures Non-Infringement Win for Teva Pharmaceuticals

Sterne, Kessler, Goldstein & Fox

Firm Announcements

August 29, 2023

U.S. District Court Affirms Immigrant Children’s Constitutional Rights

Sterne, Kessler, Goldstein & Fox

In the News

March 9, 2022

Acer Ends 4G Patent Lawsuit Against Volkswagen in U.S. Court

Reuters